101
|
Chavan MM, Kawle PD, Mehta NG. Increased sialylation and defucosylation of plasma proteins are early events in the acute phase response. Glycobiology 2005; 15:838-48. [PMID: 15858075 DOI: 10.1093/glycob/cwi067] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Within hours of turpentine injection to stimulate the acute phase (AP) response in rats, the N-acetylneuraminic acid content of plasma proteins increases and that of fucose decreases, each by about 60%. The two changes are inversely related (r = -0.97). The NeuAc/Gal ratio increases from the normal 0.75 to 1.0 on day 2 of the AP. Whereas 50% of the isolated oligosaccharides of normal plasma proteins are retarded on immobilized Ricinus communis agglutinin, those from day 2 AP plasma fail to do so. This indicates that NeuAc caps the normally Gal-terminated chains. alpha1-Acid glycoprotein (a positive AP protein), alpha1-macroglobulin (a non-AP protein), and alpha1-inhibitor3 (a negative AP protein) also show similar alterations in NeuAc/Gal ratio and decreases in Fuc. alpha2-Macroglobulin, which arises only during the AP, does not contain significant amounts of Fuc. Sambucus nigra agglutinin (alpha2,6-linked NeuAc-specific) binds a majority of plasma proteins, and binding is increased during the AP response. Maackia amurensis lectin (alpha2,3-linked NeuAc-specific) binds only three proteins in normal plasma and three additional proteins in AP plasma. The Fuc-specific Aleuria aurantia agglutinin and Lens culinaris agglutinin each detect five proteins in normal plasma. Their binding decreases during the AP response. These results show that: (1) sialylation and defucosylation of preexisting plasma proteins occur rapidly in the AP response; (2) sialylation caps the preexisting Gal-terminating oligosaccharides; and (3) the oligosaccharides of even the non-AP and negative AP proteins are modified. These changes are distinct from the elevation in the levels of protein-bound monosaccharides and the altered concanavalin A-binding profile the oligosaccharides of AP proteins acquire in diseases.
Collapse
Affiliation(s)
- Manasi M Chavan
- Biochemistry and Cell Biology, ACTREC, Navi Mumbai 410 208, India.
| | | | | |
Collapse
|
102
|
Takamatsu S, Inoue N, Katsumata T, Nakamura K, Fujibayashi Y, Takeuchi M. The Relationship between the Branch-Forming Glycosyltransferases and Cell Surface Sugar Chain Structures. Biochemistry 2005; 44:6343-9. [PMID: 15835923 DOI: 10.1021/bi047606a] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Many recombinant proteins developed or under development for clinical use are glycoproteins, and trials aimed at improving their bioactivity or pharmacokinetics in vivo by altering specific glycan structures are ongoing. For pharmaceuticals of glycoproteins, it is important to characterize and, if possible, control the glycosylation profile. However, the mechanism responsible for the regulation of sugar chain structures found on naturally occurring glycoproteins is still unclear. To clarify the relationship between glycosyltransferases and sugar chain branch structure, we estimated six glycosyltransferases' activities (N-acetylglucosaminyltransferase (GlcNAcTase)-I, -II, -III, -IV, -V, and beta-1,4-galactosyltransferase (GalT)) which control the branch formation on asparagine (Asn)-linked sugar chains in 18 human cancer cell lines derived from several tissues. To visualize the balance of glycosyltransferase activity associated with each cell line, we expressed the relative glycosyltransferase activity in comparison to the average activity among the cell lines. These cell lines were classified into five groups according to their relative glycosyltransferase balance and were termed GlcNAcTase-I/-II, GlcNAcTase-III, GlcNAcTase-IV, GlcNAcTase-V, and GalT. We also characterized the structures of Asn-linked sugar chains on the cell surface of representative cell lines of each group. The branching structure of cell surface sugar chains roughly corresponded to the glycosyltransferase balance. This finding suggests that, for the sugar chain structure remodeling of glycoproteins, attention should be focused on the glycosyltransferase balance of host cells before introducing exogenous glycosyltransferases or down-regulating the activity of intrinsic glycosyltransferases.
Collapse
Affiliation(s)
- Shinji Takamatsu
- Biomedical Imaging Research Center, University of Fukui, 23-3 Shimoaizuki, Matsuoka, Yoshida, Fukui 910-1193, Japan.
| | | | | | | | | | | |
Collapse
|
103
|
Nozaki H, Wijayagunawardane MPB, Kodituwakku SP, Yoshida T, Nakamura T, Arai I, Urashima T, Miyamoto A. N-acetylglucosaminyltransferase I activity of bovine oviduct epithelial cells: stimulation by luteinizing hormone, vascular endothelial growth factor and tumor necrosis factor alpha. J Reprod Dev 2005; 51:229-34. [PMID: 15699581 DOI: 10.1262/jrd.16083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
N-acetylglucosaminyltransferase I (GnT I; EC 2.4.1.101), which catalyzes the first step in the conversion of oligomannose to complex or hybrid N-glycans of glycoproteins, was found in media cultured with bovine oviduct epithelial cells (BOEC) obtained from non-pregnant cows during the follicular phase. Combined treatment with specific hormones increased GnT I release from BOEC. Luteinizing hormone (LH; 10 ng/ml) alone slightly, but together with 17beta-estradiol (E2; 1 ng/ml), synergistically increased GnT I activity. Vascular endothelial growth factor (VEGF) and tumor necrosis factor (TNF) alpha, which have been shown to have their highest activities in the bovine oviduct during the periovulatory period, also increased in GnT I activity. This study provides the first evidence of an increase of GnT I release from BOEC in vitro, and shows that endocrine as well as local factors such as LH, VEGF and TNFalpha increase this activity. The results suggest that GnT I activity in the bovine oviduct may contribute to the induction of glycosylation and thereby contributing to the provision of the optimal microenvironment for fertilization and early development of the embryos.
Collapse
Affiliation(s)
- Hirofumi Nozaki
- Department of Agricultural and Life Science, Obihiro University of Agriculture and Veterinary Medicine, Japan
| | | | | | | | | | | | | | | |
Collapse
|
104
|
Hoja-Łukowicz D, Butters TD, Lityńska A. Characterization of the oligosaccharide component of microsomal beta-glucuronidase from rat liver. Biochimie 2005; 86:363-72. [PMID: 15358052 DOI: 10.1016/j.biochi.2004.05.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2004] [Accepted: 05/21/2004] [Indexed: 11/18/2022]
Abstract
The oligosaccharides of microsomal beta-glucuronidase were analysed by gel permeation and weak anion exchange chromatography following hydrazine release. N-linked glycans, constituted 80% of the total glycan pool and were mainly of the tri- and biantennary complex type with or without core and arm fucose. The major oligosaccharide, that comprised 30.6% of all the species analysed, was structurally identified by reagent array analysis method and found to be a triantennary complex structure, Galbeta1,4GlcNAcbeta1,2Manalpha1,6(3)(Galbeta1,4GlcNAcbeta1,4(Galbeta1,4GlcNAcbeta1,2) Manalpha1,3(6))Manbeta1,4GlcNAcbeta1,4 GlcNAc. O-Linked glycans comprised 20% of the total glycan pool, the major species being Galbeta1,3GalNAc. All of the N- and O-linked glycans were charged. Most of the negative charge was due to sialic acid (85.0%) with the remainder being phosphate present as phosphomonoesters (7.3%) and phosphodiesters (5%). This is the first report of O-linked carbohydrate chains in microsomal beta-glucuronidase. The presence of O-linked glycans and branched N-linked glycans in a microsomal enzyme, in relation to the current view of glycosyltransferase compartmentalization in the Golgi is discussed.
Collapse
Affiliation(s)
- Dorota Hoja-Łukowicz
- Department of Animal Physiology, Institute of Zoology, Jagiellonian University, 6 Ingardena Street, 30 060 Kraków, Poland.
| | | | | |
Collapse
|
105
|
Krawczenko A, Ciszak L, Malicka-Blaszkiewicz M. Carp liver DNase—isolation, further characterization and interaction with endogenous actin. Comp Biochem Physiol B Biochem Mol Biol 2005; 140:141-51. [PMID: 15621519 DOI: 10.1016/j.cbpc.2004.09.024] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2004] [Revised: 09/27/2004] [Accepted: 09/30/2004] [Indexed: 11/16/2022]
Abstract
Deoxyribonuclease I (DNase I)-like enzyme from the liver of the carp (Cyprinus carpio) was purified to homogeneity and further characterized. Ion exchange chromatography on DEAE-cellulose, molecular filtration on Sephacryl S-300 and Con A-Sepharose affinity chromatography were applied for enzyme isolation. Carp liver DNase, similarly to DNase I from bovine pancreas, was found to be an endonuclease that hydrolyses linear DNA from salmon sperm as well as circular DNA forms--plasmid and cosmid. The purified enzyme is a glycoprotein and shows microheterogeneity, as observed in DNase zymograms prepared after native and two-dimensional electrophoresis (2D-PAGE). The composition of sugar component of the enzyme was characterized. Special attention was focused on the ability of carp liver DNase to interact with carp liver actin. The carp liver enzyme was inhibited by endogenous actin. The estimated binding constant of carp liver DNase to carp liver actin was calculated to be 1.1 x 10(6) M(-1).
Collapse
Affiliation(s)
- Agnieszka Krawczenko
- Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R.Weigla 12, 53-114 Wroclaw, Poland
| | | | | |
Collapse
|
106
|
Menon KN, Ikeda T, Fujimoto I, Narimatsu H, Nakakita SI, Hase S, Ikenaka K. Changes inN-linked sugar chain patterns induced by moderate-to-high expression of the galactosyltransferase I gene in a brain-derived cell line, CG4. J Neurosci Res 2005; 80:29-36. [PMID: 15723386 DOI: 10.1002/jnr.20416] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Oligosaccharides with biantennae and bisecting N-acetyl glucosamine (GlcNAc) residues attached to the mannose in the beta1-4 trimannosyl core (BA2) are enriched in the brain and considered brain-type sugar chains. We investigated the significance of the interplay between galactosyltransferase I (GalTase I) and BA2 formation in a brain-derived cell line, CG4. Increased GalTase expression in different glial- and neuronal-derived cell lines was accompanied by decreased or undetectable levels of BA2, depending on the level of GalTase expression. Forceful expression of GalTase I in CG4 cells expressing high levels of BA2 and low GalTase activity significantly reduced BA2 levels. In addition, a sixfold increase in an abnormal sugar chain A1(6)G1Fo and a moderate increase in A2G2Fo(6)F were evident. The increased levels of A1(6)G1Fo indicate a diversion or abrogation of the N-linked sugar chain biosynthetic pathway from normal. The accumulation of A1(6)G1Fo and increased A2G2Fo(6)F levels were accompanied by decreased levels of the high mannose-type sugar chains, M5A, M6B, M8A, and M9A. Increased GalTase I expression also led to stunted growth and abnormal morphology of CG4 cells, with increased mortality. Even moderate overexpression of GalTase I thus disrupts the normal biosynthetic pathway of N-linked sugar chains, and high overexpression is fatal to CG4 cells.
Collapse
Affiliation(s)
- Krishnakumar N Menon
- Division of Neurobiology and Bioinformatics, National Institute for Physiological Sciences, Myodaiji, Okazaki, Aichi, Japan
| | | | | | | | | | | | | |
Collapse
|
107
|
Jeong HY, Lee JY, Park TH. Specificity of enzymatic in vitro glycosylation by PNGase F: a comparison of enzymatic and non-enzymatic glycosylation. Enzyme Microb Technol 2004. [DOI: 10.1016/j.enzmictec.2004.08.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
108
|
John H, Radtke K, Ständker L, Forssmann WG. Identification and characterization of novel endogenous proteolytic forms of the human angiogenesis inhibitors restin and endostatin. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 2004; 1747:161-70. [PMID: 15698950 DOI: 10.1016/j.bbapap.2004.10.013] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 07/26/2004] [Revised: 10/27/2004] [Accepted: 10/27/2004] [Indexed: 10/26/2022]
Abstract
Restin and endostatin are C-terminal fragments of the noncollagenous domains of collagen XV and collagen XVIII exhibiting high sequence homology. Both polypeptides are distinguished by strong anti-angiogenic activity in vivo restricting the growth of solid tumors and metastasis. They are therefore currently being tested in clinical trials as anti-cancer drugs. We present the identification of new endogenous variants of both angiogenesis inhibitors isolated from a human hemofiltrate peptide library. Using an immunological screening approach with time-resolved rare earth metal fluorometry, immunoreactive compounds were purified chromatographically and characterized by mass spectrometry. We discovered four novel proteolytic products of restin as well as four variants of endostatin. Two endostatin products were characterized as short internal fragments (R176-L215 and R176-S219) of the entire molecule containing the recently identified beta1 integrin receptor binding site, which plays a major role in endothelial cell migration and angiogenesis. Two additional forms contain mucin-type O-glycosylations. The O-glycosylated variants possess an oligosaccharide unit consisting of one N-acetylgalactosamine (GalNAc), one N-acetylneuraminic acid (NANA) and two galactose residues (Gal) occurring as sialo-(V117-S311-GalNAc-Gal2-NANA) and asialoglycopeptides (V117-S311-GalNAc-Gal2). The four restin variants (R(I)-R(IV)) were identified with identical C- but different N-termini and no posttranslational modification (R(I): P66-A254, R(II): P75-A254, R(III): Y81-A254 and R(IV): A89-A254). Following a differential peptide mass fingerprint approach by reflector mode MALDI-TOFMS, the disulfide patterns of these circulating restins were determined as Cys1-Cys4 and Cys2-Cys3. These endogenous circulating collagen fragments will help to understand the physiological processing of the therapeutic proteins.
Collapse
Affiliation(s)
- Harald John
- IPF PharmaCeuticals GmbH, Feodor-Lynen-Str. 31, D-30625 Hannover, Germany.
| | | | | | | |
Collapse
|
109
|
Hyuga M, Itoh S, Kawasaki N, Ohta M, Ishii A, Hyuga S, Hayakawa T. Analysis of site-specific glycosylation in recombinant human follistatin expressed in Chinese hamster ovary cells. Biologicals 2004; 32:70-7. [PMID: 15454184 DOI: 10.1016/j.biologicals.2004.04.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2003] [Accepted: 04/01/2004] [Indexed: 10/26/2022] Open
Abstract
Follistatin (FS), a glycoprotein, plays an important role in cell growth and differentiation through the neutralization of the biological activities of activins. In this study, we analyzed the glycosylation of recombinant human FS (rhFS) produced in Chinese hamster ovary cells. The results of SDS-PAGE and MALDI-TOF MS revealed the presence of both non-glycosylated and glycosylated forms. FS contains two potential N-glycosylation sites, Asn95 and Asn259. Using mass spectrometric peptide/glycopeptide mapping and precursor-ion scanning, we found that both N-glycosylation sites were partially glycosylated. Monosaccharide composition analyses suggested the linkages of fucosylated bi- and triantennary complex-type oligosaccharides on rhFS. This finding was supported by mass spectrometric oligosaccharide profiling, in which the m/z values and elution times of some of the oligosaccharides from rhFS were in good agreement with those of standard oligosaccharides. Site-specific glycosylation was deduced on the basis of the mass spectra of the glycopeptides. It was suggested that biantennary oligosaccharides are major oligosaccharides located at both Asn95 and Asn259, whereas the triantennary structures are present mainly at Asn95.
Collapse
Affiliation(s)
- Masashi Hyuga
- Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.
| | | | | | | | | | | | | |
Collapse
|
110
|
Li LB, Chen N, Ramamoorthy S, Chi L, Cui XN, Wang LC, Reith MEA. The Role of N-Glycosylation in Function and Surface Trafficking of the Human Dopamine Transporter. J Biol Chem 2004; 279:21012-20. [PMID: 15024013 DOI: 10.1074/jbc.m311972200] [Citation(s) in RCA: 135] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The present study addressed the role of N-linked glycosylation of the human dopamine transporter (DAT) in its function with the help of mutants, in which canonical N-glycosylation sites have been removed (N181Q, N181Q,N188Q, and N181Q,N188Q,N205Q), expressed in human embryonic kidney-293 cells. Removal of canonical sites produced lower molecular weight species as did enzymatic deglycosylation or blockade of glycosylation, and all three canonical sites were found to carry sugars. Prevention of N-glycosylation reduced both surface and intracellular DAT. Although partially or non-glycosylated DAT was somewhat less represented at the surface, no evidence was found for preferential exclusion of such material from the plasma membrane, indicating that glycosylation is not essential for DAT expression. Non-glycosylated DAT was less stable at the surface as revealed by apparently enhanced endocytosis, consonant with weaker DAT immunofluorescence at the cell surface and stronger presence in cytosol in confocal analysis of the double and triple mutant. Non-glycosylated DAT did not transport dopamine as efficiently as wild-type DAT as judged from the sharp reduction in uptake V(max), and prevention of N-glycosylation enhanced the potency of cocaine-like drugs in inhibiting dopamine uptake into intact cells without changing their affinity for DAT when measured in membrane preparations prepared from these cells. Thus, non-glycosylated DAT at the cell surface displays appreciably reduced catalytic activity and altered inhibitor sensitivity compared with wild type.
Collapse
Affiliation(s)
- Li-Bin Li
- Department of Biological Sciences, Illinois State University, Normal, IL 61790, USA
| | | | | | | | | | | | | |
Collapse
|
111
|
Nozaki H, Miyamoto A, Hayashi KG, Matsui M, Yoshida T, Nakamura T, Arai I, Urashima T. N-Acetylglucosaminyltransferase I Activity in Bovine Ovarian Follicular Fluids from Dominant and Atretic Follicles. J Appl Glycosci (1999) 2004. [DOI: 10.5458/jag.51.315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
112
|
KATO K, YAMAGUCHI Y, TAKAHASHI N, NISHIMURA M, IWAMOTO SI, SEKIYA S, TANAKA K. Discrimination of Isomeric Fragment Ions Observed in Tandem Mass Spectra of Biantennary Oligosaccharides by Use of Selective Isotope Labeling. ACTA ACUST UNITED AC 2004. [DOI: 10.5702/massspec.52.284] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
113
|
Burger K, Kluge M, Koksch B, Fehn S, Böttcher C, Hennig L, Müller G. Hexafluoroacetone as Protecting and Activating Reagent: A New Approach to O-Glycosides. HETEROCYCLES 2004. [DOI: 10.3987/com-04-s(p)6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
114
|
Lakshmanan T, Sriram D, Priya K, Loganathan D. On the structural significance of the linkage region constituents of N-glycoproteins: an X-ray crystallographic investigation using models and analogs. Biochem Biophys Res Commun 2003; 312:405-13. [PMID: 14637152 DOI: 10.1016/j.bbrc.2003.10.149] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
The linkage region constituents, namely, 2-acetamido-2-deoxy-beta-D-glucopyranose and asparagine are conserved in the N-glycoproteins of all the eukaryotes. The present work is aimed at understanding the reasons for the occurrence of GlcNAc and Asn as the linkage region constituents. A total of six sugar amides have been designed as models and analogs of the linkage region and their crystal structures have been solved. This is the first report on the X-ray crystallographic investigation of the effect of systematic changes in the linkage sugar as well as its aglycon moiety on the N-glycosidic torsion, psi(N) (O5-C1-N1-C1(')). This also forms the first report on the crystal structure of a model of L-RhabetaAsn, a variant linkage found in the surface layer glycoprotein of Bacillus stearothermophillus. Among the models and analogs examined, the acetamido derivatives of Man and Xyl, the linkage sugars of O-glycoproteins, show a psi(N) value of -114.5 degrees and -121.2 degrees, respectively, deviating maximum from the value of -89.8 degrees reported for the model compound GlcNAcbetaNHAc. The L-Rha and Gal derivatives also show noticeable deviations. The psi(N) values, -89.5 degrees and -91.0 degrees, of the propionamide derivatives of Glc and GlcNAc (analogs of GlcbetaGln and GlcNAcbetaGln, respectively) agree well with those (-93.8 degrees and -89.8 degrees ) reported for their corresponding acetamide derivatives suggesting Gln could serve as well as Asn as the linkage region amino acid. However, the rotational freedom about the additional C-C bond would lead to altered rigidity of the linkage region. An analysis of packing reveals that the molecular assembly of these compounds is driven by different infinite and finite chains of hydrogen bonds. The double pillaring of hydrogen bonds involving the amide groups at C1 and C2 is seen as a unique packing feature characteristic of beta-1-N-acyl derivatives of GlcNAc. Based on the findings of the present study, it is speculated that the linkage region constituents of the eukaryotic N-glycoproteins appear to fulfill three essential structural requirements: rigidity, planarity, and linearity and these are met by the trisaccharide core and Asn at the linkage region.
Collapse
|
115
|
Khan RH, Rasheedi S, Haq SK. Effect of pH, temperature and alcohols on the stability of glycosylated and deglycosylated stem bromelain. J Biosci 2003; 28:709-14. [PMID: 14660870 DOI: 10.1007/bf02708431] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
The biological significance of the carbohydrate moiety of a glycoprotein has been a matter of much speculation. In the present work, we have chosen stem bromelain from Ananas comosus as a model to investigate the role of glycosylation of proteins. Stem bromelain is a thiol protease which contains a single hetero-oligosaccharide unit per molecule. Here, the deglycosylated form of the enzyme was obtained by periodate oxidation. The differences in the glycosylated and deglycosylated forms of the glycoprotein have been studied at various temperatures and pH values, using probes such as loss of enzyme activity and by the changes in fluorescence and circular dichroism spectra. Deglycosylated bromelain showed decreased enzyme activity and perturbed fluorescence and circular dichroism spectra. In addition to this, a comparative study of their activities in different organic solvents showed a marked decrease in case of deglycosylated form of the enzyme. It is thus concluded that glycosylation contributes towards the functional stability of glycoenzymes.
Collapse
Affiliation(s)
- Rizwan Hasan Khan
- Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh 202 002, India.
| | | | | |
Collapse
|
116
|
Patil AR, Misquith S, Dam TK, Sharma V, Kapoor M, Surolia A. Exploring enzyme amplification to characterize specificities of protein-carbohydrate recognition. Methods Enzymol 2003; 362:567-83. [PMID: 12968389 DOI: 10.1016/s0076-6879(03)01038-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/04/2023]
Affiliation(s)
- Anita Ramdas Patil
- Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045, USA
| | | | | | | | | | | |
Collapse
|
117
|
Takamatsu S, Fukuta K, Asanagi M, Abe R, Yokomatsu T, Fujibayashi Y, Makino T. Monitoring biodistribution of glycoproteins with modified sugar chains. BIOCHIMICA ET BIOPHYSICA ACTA 2003; 1622:179-91. [PMID: 12928114 DOI: 10.1016/s0304-4165(03)00141-7] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Natural human interferon (hIFN)-gamma has mainly biantennary complex-type sugar chains. Previously, we successfully remodeled its sugar chain structure into: (a) highly branched types; or (b) highly sialylated types, by overexpression of: (a) N-acetylglucosaminyltransferase (GnT)-IV and/or GnT-V; or (b) sialyltransferases, in Chinese hamster ovary (CHO) cells. In addition, we prepared asialo hIFN-gammas by treatment with sialidase in vitro. In the present study, we assessed the bioactivity of remodeled hIFN-gamma in terms of antiviral activity, anticellular activity, and biodistribution. Structural changes to the sugar chains did not have a significant influence on the antiviral and anticellular activities of hIFN-gamma, although the attachment of the sugar chain itself affected both activities. However, the biodistribution differed significantly; the number of exposed galactose residues was the major determinant of the specific distribution to the liver and blood clearance rate of hIFN-gamma. This phenomenon was considered to be mediated by the hepatic asialoglycoprotein receptor (ASGP-R), and we showed a linear, not exponential, enhancement of the distribution to the liver with an increase in the number of exposed galactose residues. We also confirmed this tendency using fibroblast growth factor (FGF). Our observation is not the same as the "glycoside cluster effect." We thus provide important information on the character of modified recombinant glycoproteins.
Collapse
Affiliation(s)
- Shinji Takamatsu
- Biomedical Imaging Research Center, Fukui Medical University, 23-3 Matsuoka, Yoshida, Fukui 910-1193, Japan
| | | | | | | | | | | | | |
Collapse
|
118
|
Evans EA, Zhang H, Martin-DeLeon PA. SPAM1 (PH-20) protein and mRNA expression in the epididymides of humans and macaques: utilizing laser microdissection/RT-PCR. Reprod Biol Endocrinol 2003; 1:54. [PMID: 12932297 PMCID: PMC184449 DOI: 10.1186/1477-7827-1-54] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2003] [Accepted: 08/06/2003] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The Sperm Adhesion Molecule 1 (SPAM1) is an important sperm surface hyaluronidase with at least three functions in mammalian fertilization. Previously our laboratory reported that in the mouse, in addition to its expression in the testis, Spam1 is synthesized in the epididymis where it is found in membranous vesicles in the principal cells of the epithelium in all three regions. Since SPAM1 is widely conserved among mammals the aim of the study was to determine if its expression pattern in the epididymis is conserved in rodents and primates. METHODS We used laser microdissection (LM)/RT-PCR on frozen and paraffin-embedded epididymal sections of humans (n = 3) and macaques (n = 2) as well as in situ transcript hybridization to determine if transcripts are present in the epididymal epithelium. Western analysis and immunohistochemistry were used to detect and confirm the protein expression, and hyaluronic acid substrate gel electrophoresis analyzed its hyaluronidase activity. An in silico analysis of the proximal promoter of SPAM1 was also performed to identify relevant putative transcription binding sites for the androgen receptor. RESULTS We demonstrate that mRNA unique to SPAM1 is present in the principal cells of the epididymal epithelium in all individuals of both species studied. SPAM1 protein is present in all three regions of the epididymis, as well as the vas deferens, and is localized similarly to the transcripts. SPAM1 was shown to have hyaluronidase activity at pH 7.0. In the proximal promoter of SPAM1 were uncovered putative epididymal transcription factor binding sites including androgen receptor elements (AREs), consistent with epididymal expression. CONCLUSIONS These findings allow us to conclude that epididymal SPAM1 is conserved in at least two mammalian classes, rodents and primates. This conservation of expression suggests that the protein is likely to play an important function, possibly in sperm maturation.
Collapse
Affiliation(s)
- Eric A Evans
- Department of Biological Sciences, University of Delaware, Newark, Delaware, USA
- Department of Genetics, Stanford University, School of Medicine, Stanford, CA 94305-6120, USA
| | - Hong Zhang
- Department of Biological Sciences, University of Delaware, Newark, Delaware, USA
| | | |
Collapse
|
119
|
Zhang H, Martin-DeLeon PA. Mouse Spam1 (PH-20) is a multifunctional protein: evidence for its expression in the female reproductive tract. Biol Reprod 2003; 69:446-54. [PMID: 12672666 DOI: 10.1095/biolreprod.102.013854] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
Sperm adhesion molecule 1 (Spam1) is a widely conserved sperm surface protein with multiple roles in mammalian fertilization. Although the gene for this protein has been thought to be testis specific based on Northern blot analysis, there is evidence for nontesticular expression when transcripts are analyzed by more sensitive techniques. In the present investigation, results of a reverse transcription polymerase chain reaction assay, an RNase-protection assay (RPA), and an in situ transcript hybridization assay revealed that the murine Spam1 gene is transcribed in the female genital tract. RPA revealed that Spam1 transcripts are synthesized in a region-dependent manner, with the oviduct having lower transcript levels than the uterus and vagina. The transcripts levels were 3- to 10-fold lower in the female genital tract than in the testis. In situ transcript hybridization assay revealed RNA in the luminal epithelium in all three regions of the genital tract and in the uterine myometrium and the oviductal mesothelium. Western blot analysis and immunohistochemistry demonstrated that the protein concentration is 1.5- to 3-fold lower in female tissues than in sperm, and localization is similar to that of the transcripts. The protein has hyaluronidase activity at neutral pH, which is unique for sperm hyaluronidase, but not at acidic pH. In the uterus, Spam1 expression fluctuated during the estrous cycle. Its localization suggests that in addition to functioning as a secretory protein, it may be involved in hyaluronic acid metabolism or turnover in the female genital tract. Our results provide further evidence that Spam1 is a multifunctional protein and that it is less restricted in its expression than previously reported.
Collapse
Affiliation(s)
- Hong Zhang
- Department of Biological Sciences, University of Delaware, Newark, Delaware 19716, USA
| | | |
Collapse
|
120
|
Nozaki H, Matsuzawa T, Nakamura T, Arai I, Urashima T. Are there two forms of beta 2-N-acetylglucosaminyltransferase I in rat testicular and epididymal fluids? BIOCHIMICA ET BIOPHYSICA ACTA 2003; 1649:140-5. [PMID: 12878032 DOI: 10.1016/s1570-9639(03)00165-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The activity of alpha 3-D-mannoside-beta-1,2-N-acetylglucosaminyltransferase I (GnT I; EC 2.4.1.101), which catalyzes the first step in the conversion of oligomannose to complex or hybrid N-glycans of glycoproteins, was detected in rat testicular and cauda epididymal fluids. The GnT I activity of testicular fluid had a pH optimum of 6.0, whereas that of the cauda epididymal fluid was optimal at pH 7.0. The enzyme in testicular fluid had an absolute requirement for either Co2+, or Mn2+, Mg2+ and Ca2+, the activity being stimulated by these cations in the above order, whereas that of cauda epididymal fluid had an absolute requirement for Mn2+ or Ca2+, with Co2+ and Mg2+ being ineffective. The specific activity of GnT I in cauda epididymal fluid was somewhat higher than in testicular fluid. The apparent Km value for alpha 1-3 alpha 1-6mannopentaose of GnT I in the testicular and epididymal fluids was 0.57 and 0.38 mM, respectively. The substrate specificity for both GnT I activities decreased in the following order: alpha1-3 alpha 1-6mannopentaose>alpha1-3 alpha 1-6mannotriose>alpha 1-3mannobiose>alpha 1-6mannobiose. These data suggest that two forms of GnT I exist in the testicular and epididymal fluids.
Collapse
Affiliation(s)
- Hirofumi Nozaki
- Department of Bioresource Science, Obihiro University of Agriculture and Veterinary Medicine, Inanda, Obihiro, Hokkaido 080-8555, Japan
| | | | | | | | | |
Collapse
|
121
|
Choi O, Tomiya N, Kim JH, Slavicek JM, Betenbaugh MJ, Lee YC. N-glycan structures of human transferrin produced by Lymantria dispar (gypsy moth) cells using the LdMNPV expression system. Glycobiology 2003; 13:539-48. [PMID: 12672704 DOI: 10.1093/glycob/cwg071] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
N-glycan structures of recombinant human serum transferrin (hTf) expressed by Lymantria dispar (gypsy moth) 652Y cells were determined. The gene encoding hTf was incorporated into a Lymantria dispar nucleopolyhedrovirus (LdMNPV) under the control of the polyhedrin promoter. This virus was then used to infect Ld652Y cells, and the recombinant protein was harvested at 120 h postinfection. N-glycans were released from the purified recombinant human serum transferrin and derivatized with 2-aminopyridine; the glycan structures were analyzed by a two-dimensional HPLC and MALDI-TOF MS. Structures of 11 glycans (88.8% of total N-glycans) were elucidated. The glycan analysis revealed that the most abundant glycans were Man1-3(+/-Fucalpha6)GlcNAc2 (75.5%) and GlcNAcMan3(+/-Fucalpha6)GlcNAc2 (7.4%). There was only approximately 6% of high-mannose type glycans identified. Nearly half (49.8%) of the total N-glycans contained alpha(1,6)-fucosylation on the Asn-linked GlcNAc residue. However alpha(1,3)-fucosylation on the same GlcNAc, often found in N-glycans produced by other insects and insect cells, was not detected. Inclusion of fetal bovine serum in culture media had little effect on the N-glycan structures of the recombinant human serum transferrin obtained.
Collapse
Affiliation(s)
- One Choi
- Department of Biology, Johns Hopkins University, 3400 North Charles Street, Baltimore, MD 21218, USA
| | | | | | | | | | | |
Collapse
|
122
|
Zhao JH, Zhang Y, Zhang XY, Chen HL. Alteration in the expression of early stage processing enzymes of N-glycan during myeloid and monocytoid differentiation of HL-60 cells. Leuk Res 2003; 27:599-605. [PMID: 12681359 DOI: 10.1016/s0145-2126(02)00226-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The expressions of the enzymes participating in the early stage of N-glycan processing, Golgi alpha-Mase-I, alpha-Mase-II and GnT-I, GnT-II, were studied before and after HL-60 cells were differentiated to myelocytes or monocytes induced by ATRA or PMA, respectively. It was found that alpha-Mase-I activity and GnT-I mRNA were decreased by both ATRA and PMA, while alpha-Mase-II and GnT-II were altered insignificantly. The down-regulation of alpha-Mase-I and GnT-I was cell specific, since ATRA up-regulated alpha-Mase-I and GnT-I in the H7721 hepatocarcinoma cell line. However, in H7721 cells, PMA also decreased alpha-Mase-I and GnT-I, and both ATRA and PMA also did not obviously change the expressions of alpha-Mase-II and GnT-II.
Collapse
Affiliation(s)
- Jia-Hong Zhao
- Key Laboratory of Glycoconjugate Research, Department of Biochemistry, Ministry of Health, School of Medicine, Fudan University, 200032, Shanghai, China
| | | | | | | |
Collapse
|
123
|
Zhu D, Shen A, Wang Y, Gu X, Gu J. Developmental regulation of beta-1,3-galactosyltransferase-1 gene expression in mouse brain. FEBS Lett 2003; 538:163-7. [PMID: 12633872 DOI: 10.1016/s0014-5793(03)00168-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
beta-1,3-galactosyltransferase-1 (beta3GalT-1) is the key enzyme to form the type 1 chain structure. Northern blot analysis indicated that beta3GalT-1 was expressed predominantly in the brain. In the present study, it was revealed that the gene expression of beta3GalT-1 in mouse brain was developmentally decreased. High expression levels of beta3GalT-1 were found in cerebral cortex and hippocampus in both newborn and adult mice, while in cerebellum, the expression levels decreased markedly during development. In situ hybridization revealed that the absence of expression in cerebellar granual cell layers contributed to the main loss of beta3GalT-1 expression in adult mouse cerebellum. Moreover, the decreased levels of beta3GalT-1 could affect the synthesis of type 1 chain oligosaccharides, as revealed by immunohistochemistry analysis.
Collapse
Affiliation(s)
- Dan Zhu
- Box 103, Gene Research Center, Shanghai Medical College of Fudan University (Former Shanghai Medical University), Shanghai 200032, PR China
| | | | | | | | | |
Collapse
|
124
|
Joseph JS, Valiyaveettil M, Gowda DC, Kini RM. Occurrence of O-linked Xyl-GlcNAc and Xyl-Glc disaccharides in trocarin, a factor Xa homolog from snake venom. J Thromb Haemost 2003; 1:545-50. [PMID: 12871464 DOI: 10.1046/j.1538-7836.2003.00090.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Trocarin is a 46515-Da group D prothrombin-activating glycoprotein from the venom of the Australian elapid, Tropidechis carinatus. Amino acid sequencing and functional characterization of trocarin demonstrated that it is a structural and functional homolog of mammalian blood coagulation factor (F)Xa. In this study we show that, in contrast to mammalian Xa, which is not glycosylated, trocarin contains an O-linked carbohydrate moiety in its light chain and an N-linked carbohydrate oligosaccharide in its heavy chain. Mass spectrometry and sugar compositional analysis indicate that the O-linked carbohydrate moiety is a mixture of Xyl-GlcNAc-, GlcNAc-, Xyl-Glc- and Glc- structures linked to Ser 52. The N-linked carbohydrate on Asn 45 of the heavy chain is a sialylated, diantennary oligosaccharide that is located at the lip of the active site of the prothrombin activator.
Collapse
Affiliation(s)
- J S Joseph
- Department of Biochemistry, Faculty of Medicine, National University of Singapore, Singapore
| | | | | | | |
Collapse
|
125
|
Rao VS, Joseph JS, Kini RM. Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa. Biochem J 2003; 369:635-42. [PMID: 12403650 PMCID: PMC1223123 DOI: 10.1042/bj20020889] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2002] [Revised: 10/10/2002] [Accepted: 10/28/2002] [Indexed: 11/17/2022]
Abstract
Procoagulant venoms of several Australian elapids contain proteinases that specifically activate prothrombin; among these, Group D activators are functionally similar to coagulation factor Xa (FXa). Structural information on this class of prothrombin activators will contribute significantly towards understanding the mechanism of FXa-mediated prothrombin activation. Here we present the purification of Group D prothrombin activators from three Australian snake venoms (Hoplocephalus stephensi, Notechis scutatus scutatus and Notechis ater niger) using a single-step method, and their N-terminal sequences. The N-terminal sequence of the heavy chain of hopsarin D (H. stephensi) revealed that a fully conserved Cys-7 was substituted with a Ser residue. We therefore determined the complete amino acid sequence of hopsarin D. Hopsarin D shows approximately 70% similarity with FXa and approximately 98% similarity with trocarin D, a Group D prothrombin activator from Tropidechis carinatus. It possesses the characteristic Gla domain, two epidermal growth factor-like domains and a serine proteinase domain. All residues important for catalysis are conserved, as are most regions involved in interactions with factor Va and prothrombin. However, there are some structural differences. Unlike FXa, hopsarin D is glycosylated in both its chains: in light-chain residue 52 and heavy-chain residue 45. The glycosylation on the heavy chain is a large carbohydrate moiety adjacent to the active-site pocket. Overall, hopsarin D is structurally and functionally similar to mammalian coagulation FXa.
Collapse
Affiliation(s)
- Veena S Rao
- Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore 119260
| | | | | |
Collapse
|
126
|
Abstract
Mammalian cells produce many glycoproteins, i.e., proteins with covalently attached sugar chains. Recent advances in glycobiology have revealed the importance of sugar chains as biosignals for multi-cellular organisms including cell-cell communication, intracellular signaling, protein folding, and targeting of proteins within cells. The O-mannosyl linkage, which used to be considered specific to yeast, has recently been found in mammals. One of the best known O-mannosyl-modified glycoproteins is alpha-dystroglycan, which is a central component of the dystrophin-glycoprotein complex isolated from skeletal muscle membranes. We have identified and characterized a glycosyltransferase, UDP-N-acetylglucosamine: protein O-mannose beta1,2-N-acetylglucosaminyltransferase (POMGnT1), involved in the biosynthesis of O-mannosyl glycans. We subsequently found that loss of function of the POMGnT1 gene is responsible for muscle-eye-brain disease (MEB). MEB is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities and brain malformation (type II lissencephaly). Moreover, recent data suggest that aberrant protein glycosylation of alpha-dystroglycan is the primary cause of some forms of congenital muscular dystrophy. Here we review new insights into the glycobiology of muscular dystrophy and neuronal migration disorder.
Collapse
Affiliation(s)
- Tamao Endo
- Glycobiology Research Group, Tokyo Metropolitan Institute of Gerontology, Foundation for Research on Aging and Promotion of Human Welfare, Tokyo, Japan.
| | | |
Collapse
|
127
|
Abstract
Congenital disorders of glycosylation (CDGs) are due to defects in the synthesis of the glycan moiety of glycoproteins or other glycoconjugates. This review is devoted mainly to the clinical aspects of protein glycosylation defects. There are two main types of protein glycosylation: N-glycosylation and O-glycosylation. N-glycosylation generally consists of an assembly pathway (in cytosol and endoplasmic reticulum) and a processing pathway (in endoplasmic reticulum and Golgi). O-glycosylation lacks a processing pathway but is otherwise more complex. Sixteen disease-causing defects are known in protein glycosylation: 12 in N-glycosylation and four in O-glycosylation. The N-glycosylation defects comprise eight assembly defects (CDG-I) designated CDG-Ia to CDG-Ih, and four processing defects (CDG-II) designated CDG-IIa to CDG-IId. By far the most frequent is CDG-Ia (phosphomannomutase-2 deficiency). It affects the nervous system and many other organs. Its clinical expression varies from extremely severe to very mild (and thus probably underdiagnosed). The most interesting disease in this group is CDG-Ib (phosphomannose isomerase deficiency) because it is so far the only efficiently treatable CDG (mannose treatment). It has a hepatic-intestinal presentation. The O-glycosylation defects comprise two O-xylosylglycan defects (a progeroid variant of Ehlers-Danlos syndrome and the multiple exostoses syndrome) and two O-mannosylglycan defects (Walker-Warburg syndrome and muscle-eye-brain disease). All known CDGs have a recessive inheritance except for multiple exostoses syndrome, which is dominantly inherited. There is a rapidly growing group of putative CDGs with a large spectrum of clinical presentations (CDG-x). Serum transferrin iso-electrofocusing remains the cornerstone of the screening for N-glycosylation defects associated with sialic acid deficiency. Abnormal patterns can be grouped in to type 1 and type 2. However, a normal pattern does not exclude these defects. Screening for the other CDGs is much more difficult, particularly when the defect is organ- or system-restricted. The latter group promises to become an important new chapter in CDG. It is concluded that CDGs will eventually cover the whole clinical spectrum of paediatric and adult disease manifestations.
Collapse
Affiliation(s)
- J Jaeken
- Department of Pediatrics, Centre for Metabolic Disease, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.
| |
Collapse
|
128
|
Galili U, Ishida H, Tanabe K, Toma H. Anti-gal A/B, a novel anti-blood group antibody identified in recipients of abo-incompatible kidney allografts. Transplantation 2002; 74:1574-80. [PMID: 12490791 DOI: 10.1097/00007890-200212150-00015] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND The most prevalent anticarbohydrate antibodies in human serum are anti-Gal interacting specifically with the alpha-gal epitope (Galalpha1-3Galbeta1-4GlcNAc-R) and anti-blood group antibodies interacting with blood group A and B antigens. The alpha-gal epitope, although absent in humans, comprises part of the core of carbohydrate chain in A and B antigens. Therefore, it was of interest to determine whether immunoglobulin (Ig) G antibodies, elicited in patients rejecting ABO-incompatible kidney allografts, can interact with the alpha-gal epitope. METHODS Anti-A and anti-B antibodies were determined by enzyme-linked immunosorbent assay (ELISA) with blood group A or B human red cell membranes, as solid phase antigens. Anti-Gal was determined by ELISA with alpha-gal-bovine serum albumin as solid-phase antigen. Specific removal of anti-Gal was performed by adsorption on fixed rabbit red cells. RESULTS Blood group O patients who underwent transplantation with either A or B kidney produced an antibody that bound to all three carbohydrate antigens. This multispecific antibody, designated anti-Gal A/B, is specific to the core alpha-gal epitope within A and B antigens. Recipients of allograft expressing incompatible blood group B also produce anti-Gal B antibody, which binds to the core alpha-gal epitope only in the B antigen. Anti-Gal A/B and anti-Gal B constitute most of the elicited anti-blood group antibody response. Allograft recipients also produced pure anti-A, or pure anti-B, which require the complete blood group structure for binding. CONCLUSIONS The findings in this study imply that much of the immune response elicited by incompatible A or B antigens on kidney allografts results in activation of anti-Gal B-cell clones producing antibodies to the core alpha-gal epitope in these blood group antigens. Only less than 25% of the elicited antibodies interact with the complete A or B antigens (i.e., pure anti-A or pure anti-B). These findings suggest that prevention of the anti-Gal response may decrease the immune rejection of ABO-incompatible allografts.
Collapse
Affiliation(s)
- Uri Galili
- Department of Cardiovascular-Thoracic Surgery, Rush University, Chicago, IL 60612, USA.
| | | | | | | |
Collapse
|
129
|
Abstract
Due to their diversity and external location on cell membranes, glycans, as glycocalyx components, are key elements in eukaryotic cell, tissue, and organ homeostasis. Although information on the lung glycocalyx is scarce, this article aims to review, discuss, and summarize what is known about bronchoalveolar glycocalyx composition, mainly the sialic acids. It was deemed relevant, however, to make a brief introductory overview of the cell glycocalyx and its particular development in epithelial cells. After that, follows a summary of the evolution of the knowledge regarding the bronchoalveolar glycocalyx composition throughout the years, particularly its morphological features. Since sialic acids are located terminally on the bronchoalveolar lining cells' glycocalyx and play crucial roles, we focused mainly on the existing lung histochemical and biochemical data of these sugar residues, as well as their evolution throughout lung development. The functions of the lung glycocalyx sialic acids are discussed and interpretations of their roles analyzed, including those related to the negative overall superficial shield provided by these molecules. The increasing presence of these sugar residues throughout postnatal lung development should be regarded as pivotal in the development and maintenance of a dynamic bronchoalveolar architecture, supporting the normal histophysiology of the respiratory system. The case for a profound knowledge of lung glycocalyx--given its potential to provide answers to serious clinical problems--is made with particular reference to cystic fibrosis. Finally, concluding remarks and perspectives for future research in this field are put forth.
Collapse
Affiliation(s)
- Maria de Fátima Martins
- Institute of Histology and Embryology and Center for Histophysiology, Experimental Pathology and Developmental Biology, Faculty of Medicine, University of Coimbra, Portugal
| | | |
Collapse
|
130
|
Abstract
CONTEXT Over the past 15 years the causative genes of several inherited muscular dystrophies have been identified. These genes encode sarcolemmal, extracellular matrix, sarcomeric, and nuclear envelope proteins. Although the post-translational processing of muscle proteins has a significant role in their correct assembly and function, these processes have not been shown to be primarily involved in the pathogenesis of muscular dystrophies until recently. In the past 18 months, four different forms of inherited muscular dystrophy in human beings have been associated with mutations in genes encoding for putative glycosyltransferases. Aberrant glycosylation of alpha-dystroglycan, an external membrane protein expressed in muscle, brain, and other tissues, is a common feature in these disorders. alpha-dystroglycan is highly glycosylated, its sugar components varying in different tissues and controlling its interaction with extracellular matrix partners. Disrupted glycosylation of alpha-dystroglycan results in a loss of these interactions, giving rise to both progressive muscle degeneration and abnormal neuronal migration in the brain. STARTING POINT Kevin Campbell and colleagues have recently demonstrated that patients with muscle-eye-brain disease (MEB) and Fukuyama congenital muscular dystrophy (FCMD), as well as the myodystrophy (myd) mouse, have an abnormally glycosyated form of alpha-dystroglycan (Nature 2002; 418: 417-22 and 422-25). The abnormally glycosylated protein did not bind to three of its extracellular matrix ligands, laminin alpha2 chain, agrin, and neurexin. The investigators also showed that a neuronal migration disorder occurs in both the myd mouse and in a brain-restricted alpha-dystroglycan knock-out mouse that is similar to that seen in patients with MEB and FCMD. These results identify alpha-dystroglycan as having an essential role in both muscle and brain development and function. WHERE NEXT Emphasis is moving away from identifying the protein components of the muscle fibre that are involved in muscular dystrophies towards the post-translational processing of proteins and the enzymes involved in these modifications. This opens up new avenues of research. Abnormal glycosylation of alpha-dystroglycan may underlie other as yet uncharacterised forms of muscular dystrophy and neuronal migration disorders.
Collapse
Affiliation(s)
- Francesco Muntoni
- The Dubowitz Neuromuscular Centre, Department of Paediatrics, Imperial College London, Hammersmith Hospital Campus, W12 0NN, London, UK.
| | | | | | | | | |
Collapse
|
131
|
Beltrán-Valero de Bernabé D, Currier S, Steinbrecher A, Celli J, van Beusekom E, van der Zwaag B, Kayserili H, Merlini L, Chitayat D, Dobyns WB, Cormand B, Lehesjoki AE, Cruces J, Voit T, Walsh CA, van Bokhoven H, Brunner HG. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002; 71:1033-43. [PMID: 12369018 PMCID: PMC419999 DOI: 10.1086/342975] [Citation(s) in RCA: 474] [Impact Index Per Article: 21.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2002] [Accepted: 07/16/2002] [Indexed: 11/03/2022] Open
Abstract
Walker-Warburg syndrome (WWS) is an autosomal recessive developmental disorder characterized by congenital muscular dystrophy and complex brain and eye abnormalities. A similar combination of symptoms is presented by two other human diseases, muscle-eye-brain disease (MEB) and Fukuyama congenital muscular dystrophy (FCMD). Although the genes underlying FCMD (Fukutin) and MEB (POMGnT1) have been cloned, loci for WWS have remained elusive. The protein products of POMGnT1 and Fukutin have both been implicated in protein glycosylation. To unravel the genetic basis of WWS, we first performed a genomewide linkage analysis in 10 consanguineous families with WWS. The results indicated the existence of at least three WWS loci. Subsequently, we adopted a candidate-gene approach in combination with homozygosity mapping in 15 consanguineous families with WWS. Candidate genes were selected on the basis of the role of the FCMD and MEB genes. Since POMGnT1 encodes an O-mannoside N-acetylglucosaminyltransferase, we analyzed the possible implication of O-mannosyl glycan synthesis in WWS. Analysis of the locus for O-mannosyltransferase 1 (POMT1) revealed homozygosity in 5 of 15 families. Sequencing of the POMT1 gene revealed mutations in 6 of the 30 unrelated patients with WWS. Of the five mutations identified, two are nonsense mutations, two are frameshift mutations, and one is a missense mutation. Immunohistochemical analysis of muscle from patients with POMT1 mutations corroborated the O-mannosylation defect, as judged by the absence of glycosylation of alpha-dystroglycan. The implication of O-mannosylation in MEB and WWS suggests new lines of study in understanding the molecular basis of neuronal migration.
Collapse
Affiliation(s)
- Daniel Beltrán-Valero de Bernabé
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Sophie Currier
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Alice Steinbrecher
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Jacopo Celli
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Ellen van Beusekom
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Bert van der Zwaag
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Hülya Kayserili
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Luciano Merlini
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - David Chitayat
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - William B. Dobyns
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Bru Cormand
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Ana-Elina Lehesjoki
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Jesús Cruces
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Thomas Voit
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Christopher A. Walsh
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Hans van Bokhoven
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| | - Han G. Brunner
- Departments of Human Genetics and Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Division of Neurogenetics, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Institute of Neuropathology, Free University Berlin, Berlin; Department of Pediatrics and Pediatric Neurology, University Hospital Essen, Essen; Department of Neurology, Division of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul; Laboratory of Neuromuscular Pathology, Istituto Ortopedico Rizzoli, Bologna; Department of Obstetrics and Gynecology, Mount Sinai Hospital, The University of Toronto, Toronto; Departments of Human Genetics, Neurology, and Pediatrics, The University of Chicago, Chicago; Department of Genetics, University of Barcelona, Barcelona; Folkhalsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki; and Department of Biochemistry, Faculty of Medicine, University Autónoma of Madrid, Madrid
| |
Collapse
|
132
|
Takasu A, Houjyou T, Inai Y, Hirabayashi T. Three-dimensional arrangement of sugar residues along a helical polypeptide backbone: synthesis of a new type of periodic glycopeptide by polymerization of a beta-O-glycosylated tripeptide containing alpha-aminoisobutyric acid. Biomacromolecules 2002; 3:775-82. [PMID: 12099822 DOI: 10.1021/bm020014s] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
A new type of glycopeptide having a periodic sequence of -[L-Glu(OMe)-Ser(beta-D-GlcNAc)-Aib]- was synthesized by polymerization of a glycosylated tripeptide with diphenylphosphoryl azide (DPPA) and active ester methods using H-L-Glu(OMe)-Ser[beta-D-GlcNAc(Ac)(3)]-Aib-OH (13) and H-L-Glu(OMe)-Ser[beta-D-GlcNAc(Ac)(3)]-Aib-ONp (15, Np = p-nitrophenyl) as the monomers, respectively. Number-average molecular weights were determined by size exclusion chromatography (SEC) and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, those in the latter method were higher than those in the former one. CD and FT IR spectra of poly(13) and poly(15) indicated that they form right-handed helical conformations. Deacetylation of the acetylated glycopeptide was established without racemization using hydrazine/methanol. CD spectra of the deacetylated glycopeptides 16 (21 and 24 residues) in water showed negative Cotton effect at wavelength of 208 and 222 nm indicating an alpha-helical conformation, i.e., N-acetyl-D-glucosamine (GlcNAc) moieties were arranged spatially along the alpha-helical peptide keeping a specific distance and orientation in water. Addition of ethanol to aqueous solutions of the periodic glycopolymer 16 resulted in an increase in the alpha-helix content. Semiempirical molecular orbital calculation also supported the alpha-helical conformation of 16.
Collapse
Affiliation(s)
- Akinori Takasu
- Department of Environmental Technology and Urban Planning, Graduate School of Engineering, Nagoya Institute of Technology, Gokiso-cho, Showa-ku, Nagoya 466-8555, Japan.
| | | | | | | |
Collapse
|
133
|
Kaftzik N, Wasserscheid P, Kragl U. Use of Ionic Liquids to Increase the Yield and Enzyme Stability in the β-Galactosidase Catalysed Synthesis of N-Acetyllactosamine. Org Process Res Dev 2002. [DOI: 10.1021/op0255231] [Citation(s) in RCA: 162] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Nicole Kaftzik
- Rostock University, Deptartment of Chemistry, 18051 Rostock, Germany, and Institute of Technical and Macromolecular Chemistry, RWTH Aachen, 52066 Aachen, Germany
| | - Peter Wasserscheid
- Rostock University, Deptartment of Chemistry, 18051 Rostock, Germany, and Institute of Technical and Macromolecular Chemistry, RWTH Aachen, 52066 Aachen, Germany
| | - Udo Kragl
- Rostock University, Deptartment of Chemistry, 18051 Rostock, Germany, and Institute of Technical and Macromolecular Chemistry, RWTH Aachen, 52066 Aachen, Germany
| |
Collapse
|
134
|
Stahl B, Thurl S, Henker J, Siegel M, Finke B, Sawatzki G. Detection of four human milk groups with respect to Lewis-blood-group-dependent oligosaccharides by serologic and chromatographic analysis. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2002; 501:299-306. [PMID: 11787693 DOI: 10.1007/978-1-4615-1371-1_37] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Oligosaccharides from human milk samples obtained from individual donors were analyzed using high-pH anion-exchange chromatography. Three patterns of neutral oligosaccharides were detected corresponding to milk groups already described. These oligosaccharide groups correspond to the Lewis blood types Le(a-b+), Le(a+b-), and Le(a-b-). A new carbohydrate pattern was detected in a milk sample from a Le(a-b-) person in which only nonfucosylated oligosaccharides and compounds bearing alpha1,3-linked fucosyl residues were found. This finding led to the hypothesis that there exist 4 different oligosaccharide milk groups that fit well to the genetic basis of the Lewis blood group system.
Collapse
Affiliation(s)
- B Stahl
- Numico Research Germany, Friedrichsdorf
| | | | | | | | | | | |
Collapse
|
135
|
Abirami S, Ma N, Goh N. A Gaussian-3 (G3) theoretical study of the interactions between alkali metal cations and polyhydroxyl ligands. Chem Phys Lett 2002. [DOI: 10.1016/s0009-2614(02)00743-1] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
136
|
|
137
|
Winblade ND, Schmökel H, Baumann M, Hoffman AS, Hubbell JA. Sterically blocking adhesion of cells to biological surfaces with a surface-active copolymer containing poly(ethylene glycol) and phenylboronic acid. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 2002; 59:618-31. [PMID: 11774323 DOI: 10.1002/jbm.1273] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Graft copolymers were designed that could spontaneously bind to biological surfaces and block subsequent recognition and adhesion at those surfaces. Phenylboronic acid (PBA) moieties in the polymer backbone provided binding to surfaces, forming reversible covalent complexes with cis-diols found in many biological molecules. Pendant poly(ethylene glycol) (PEG) side chains sterically protected those surfaces from subsequent interactions with other proteins and cells. The PEG and PBA grafting ratios on these poly-L-lysine-graft-(PEG;PBA) copolymers [PLL-g-(PEG;PBA)] were varied, and the polymers were tested in models relevant to undesirable wound-healing responses such as peritoneal adhesion formation and posterior capsule opacification. PLL-g-(PEG;PBA) polymers spontaneously coated tissue culture polystyrene and completely blocked rabbit lens epithelial cell adhesion to the surface over a wide range of PEG grafting ratios. PLL-g-(PEG;PBA)s with optimal grafting ratios were able to coat adsorbed serum proteins or extracellular matrices and block cell spreading on the surfaces at 4 h, although the effect was lost within 24 h. The polymer also enhanced the efficacy of surgical lysis of peritoneal adhesions in rats. The reversible covalent complexes formed by the PBA moieties on the copolymer backbone were more effective at binding biological surfaces than electrostatic interactions formed via a copolymer lacking the PBA moieties, that is, PLL-g-PEG.
Collapse
Affiliation(s)
- Natalie D Winblade
- Department of Chemical Engineering, California Institute of Technology, Pasadena, California, USA
| | | | | | | | | |
Collapse
|
138
|
Liu F, Zaidi T, Iqbal K, Grundke-Iqbal I, Merkle RK, Gong CX. Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease. FEBS Lett 2002; 512:101-6. [PMID: 11852060 DOI: 10.1016/s0014-5793(02)02228-7] [Citation(s) in RCA: 106] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
In Alzheimer's disease (AD) brain, microtubule-associated protein tau is abnormally modified by hyperphosphorylation and glycosylation, and is aggregated as neurofibrillary tangles of paired helical filaments. To investigate the role of tau glycosylation in neurofibrillary pathology, we isolated various pools of tau protein from AD brain which represent different stages of tau pathology. We found that the non-hyperphosphorylated tau from AD brain but not normal brain tau was glycosylated. Monosaccharide composition analyses and specific lectin blots suggested that the tau in AD brain was glycosylated mainly through N-linkage. In vitro phosphorylation indicated that the glycosylated tau was a better substrate for cAMP-dependent protein kinase than the deglycosylated tau. These results suggest that the glycosylation of tau is an early abnormality that can facilitate the subsequent abnormal hyperphosphorylation of tau in AD brain.
Collapse
Affiliation(s)
- Fei Liu
- Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA
| | | | | | | | | | | |
Collapse
|
139
|
Abstract
The preparation of receptors for saccharide recognition in a natural environment has been an unmet goal for a long time. We present herein the synthesis and binding properties of (R,S)-1,1'-binaphthyl-substituted macrocycles as receptors for saccharide recognition in water/acetonitrile (1:1) and in DMSO. Porphyrin and metalloporphyrin macrocycles with two to four 1,1'-binaphthyl substituents and multiple hydroxy groups generate a binding site for saccharides that incorporates hydrogen-bonding hydroxy groups together with the aromatic hydrophobic pocket. The specificity for di- and trisaccharides is governed by the cavity size. The mechanism of binding has been studied by 1H NMR spectroscopy and the role of H-bonding and CH-pi interactions has been evaluated; the ability to bind saccharides has been demonstrated by the surface plasmon resonance (SPR) technique. The application of these macrocyclic receptors to sensor development is also presented.
Collapse
Affiliation(s)
- Oleksandr Rusin
- Institute of Chemical Technology, Department of Analytical Chemistry, Prague, Czech Republic
| | | | | |
Collapse
|
140
|
Fukuta K, Abe R, Yokomatsu T, Minowa MT, Takeuchi M, Asanagi M, Makino T. The widespread effect of beta 1,4-galactosyltransferase on N-glycan processing. Arch Biochem Biophys 2001; 392:79-86. [PMID: 11469797 DOI: 10.1006/abbi.2001.2421] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We investigated beta 1,4-GalT (UDP-galactose: beta-d-N-acetylglucosaminide beta 1,4-galactosyltransferase) in terms of intracellular competition with GnT-IV (UDP-N-acetylglucosamine: alpha1,3-d-mannoside beta1,4-N-acetylglucosaminyltransferase) and GnT-V (UDP-N-acetylglucosamine: alpha1,6-d-mannoside beta 1,6-N-acetylglucosaminyltransferase). The beta 1,4-GalT-I gene was introduced into Chinese hamster ovary (CHO) cells producing human interferon (hIFN)-gamma (IM4/V/IV cells) and five clones expressing various levels of beta 1,4-GalT were isolated. As we previously reported, parental IM4/V/IV cells express high levels of GnT-IVa and -V and produce hIFN-gamma having primarily tetraantennary sugar chains. The branching of sugar chains on hIFN-gamma was suppressed in the beta 1,4-GalT-enhanced clones to a level corresponding to the intracellular activity of beta 1,4-GalT relative to GnTs. Moreover, the contents of hybrid-type and high-mannose-type sugar chains increased in these clones. The results showed that beta 1,4-GalT widely affects N-glycan processing by competing with GnT-IV, GnT-V, and alpha-mannosidase II in cells and also by some other mechanisms that suppress the conversion of high-mannose-type sugar chains to the hybrid type.
Collapse
Affiliation(s)
- K Fukuta
- Life Science Laboratory, Mitsui Chemicals, Incorporated, 1144 Togo, Mobara, Chiba 297-0017, Japan.
| | | | | | | | | | | | | |
Collapse
|
141
|
Abstract
This mini review surveys the major accomplishments in the field of glycoconjugates research in Japan, which were made after World War II. It describes early movements in the field of glycoconjugate research in Japan, development of the new techniques to investigate structures of the sugar chains of glycoconjugates, studies of the functions of the sugar chain moieties, and the political movement in Japan to support the basic research necessary for the development of glycotechnology. As introduced in this short article, important groundwork for glycobiology was made by Japanese researchers.
Collapse
Affiliation(s)
- A Kobata
- University of Tokyo and the Tokyo Metropolitan Institute of Gerontology, 5-18-2 Tsurumaki, Tama-shi, Tokyo 206-0034, Japan
| |
Collapse
|
142
|
Aouffen M, Paquin J, Grandpré ED, Nadeau R, Mateescu MA. Deglycosylated ceruloplasmin maintains its enzymatic, antioxidant, cardioprotective, and neuronoprotective properties. Biochem Cell Biol 2001. [DOI: 10.1139/o01-125] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Ceruloplasmin (CP), an important serum antioxidant, is a blue copper glycoprotein with ferroxidase and oxidase activities. Among other physiological actions, plasma CP was shown to protect isolated rat hearts and cultured P19 neurons exposed to oxidative stress conditions, raising the possibility of using this protein in the treatment of cardiac and neuronal diseases related to oxidative damage. However, since therapeutic applications of CP must be compatible with restrictions in the administration of blood derivatives to humans, there is a need to produce the protein by genetic engineering. To help in the choice of adequate expression systems, we undertook this study to determine if the carbohydrate moiety on the protein is essential for its functions. CP was completely deglycosylated using N-glycosidase F under nondenaturing conditions. Deglycosylated CP was found to retain most of the conformational, antioxidant, and enzymatic properties of the native protein in vitro. Moreover, both forms of the protein had similar cardioprotective and neuronoprotective effects against oxidative stress as evaluated with isolated rat hearts undergoing ischemiareperfusion and with cultured P19 neurons exposed to xanthine xanthine oxidase. The data thus indicate that the carbohydrate moiety of CP is not essential for its enzymatic and protective actions. Accordingly, even the use of expression systems that do not glycosylate mammalian proteins could provide a recombinant CP that retains its therapeutic potential.Key words: copperproteins, protein-linked carbohydrates, ischemia-reperfusion, isolated rat hearts, cultured P19 neurons.
Collapse
|
143
|
Raju TS, Briggs JB, Chamow SM, Winkler ME, Jones AJ. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. Biochemistry 2001; 40:8868-76. [PMID: 11467948 DOI: 10.1021/bi010475i] [Citation(s) in RCA: 88] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Therapeutic glycoproteins produced in different host cells by recombinant DNA technology often contain terminal GlcNAc and Gal residues. Such glycoproteins clear rapidly from the serum as a consequence of binding to the mannose receptor and/or the asialoglycoprotein receptor in the liver. To increase the serum half-life of these glycoproteins, we carried out in vitro glycosylation experiments using TNFR-IgG, an immunoadhesin molecule, as a model therapeutic glycoprotein. TNFR-IgG is a disulfide-linked dimer of a polypeptide composed of the extracellular portion of the human type 1 (p55) tumor necrosis factor receptor (TNFR) fused to the hinge and Fc regions of the human IgG(1) heavy chain. This bivalent antibody-like molecule contains four N-glycosylation sites per polypeptide, three in the receptor portion and one in the Fc. The heterogeneous N-linked oligosaccharides of TNFR-IgG contain sialic acid (Sia), Gal, and GlcNAc as terminal sugar residues. To increase the level of terminal sialylation, we regalactosylated and/or resialylated TNFR-IgG using beta-1,4-galactosyltransferase (beta1,4GT) and/or alpha-2,3-sialyltransferase (alpha2,3ST). Treatment of TNFR-IgG with beta1,4GT and UDP-Gal, in the presence of MnCl(2), followed by MALDI-TOF-MS analysis of PNGase F-released N-glycans showed that the number of oligosaccharides with terminal GlcNAc residues was significantly decreased with a concomitant increase in the number of terminal Gal residues. Similar treatment of TNFR-IgG with alpha2,3ST and CMP-sialic acid (CMP-Sia), in the presence of MnCl(2), produced a molecule with an approximately 11% increase in the level of terminal sialylation but still contained oligosaccharides with terminal GlcNAc residues. When TNFR-IgG was treated with a combination of beta1,4GT and alpha2,3ST (either in a single step or in a stepwise fashion), the level of terminal sialylation was increased by approximately 20-23%. These results suggest that in vitro galactosylation and sialylation of therapeutic glycoproteins with terminal GlcNAc and Gal residues can be achieved in a single step, and the results are similar to those for the stepwise reaction. This type of in vitro glycosylation is applicable to other glycoproteins containing terminal GlcNAc and Gal residues and could prove to be useful in increasing the serum half-life of therapeutic glycoproteins.
Collapse
Affiliation(s)
- T S Raju
- Analytical Chemistry, Genentech Inc., One DNA Way, South San Francisco, California 94080, USA.
| | | | | | | | | |
Collapse
|
144
|
Shen Z, Warren CD, Newburg DS. Resolution of structural isomers of sialylated oligosaccharides by capillary electrophoresis. J Chromatogr A 2001; 921:315-21. [PMID: 11471815 DOI: 10.1016/s0021-9673(01)00872-x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
The resolution of structural isomers in mixtures of oligosaccharides is often challenging. Capillary electrophoresis was employed to separate three sets of structural isomers of sialylated oligosaccharides found in human milk and bovine colostrum. Different running buffers were necessary to achieve optimal baseline resolution. To resolve 3'- and 6'-sialyllactoses, 0.2 M aqueous sodium phosphate containing 40% methanol as an organic modifier was used as a running buffer. To resolve 3'- and 6'-sialyllactosamines, 0.4 M aqueous sodium phosphate without organic modifier was used. Baseline resolution of sialyllacto-N-tetraose-a and -b and sialyllacto-N-neotetraose-c was achieved with a 0.4 M Tris-HCl buffer containing 250 mM sodium dodecyl sulfate and 10% methanol as the organic modifier. Thus, each of these sets of structural isomers of sialylated oligosaccharides required a unique running buffer with respect to buffer type, concentration, pH, presence of organic modifiers, and surfactants. Similar electrophoresis conditions may be useful for resolving and analyzing other structural isomers of acidic oligosaccharides by capillary electrophoresis.
Collapse
Affiliation(s)
- Z Shen
- Program in Glycobiology, Shriver Center for Mental Retardation, Waltham, MA 02452, USA
| | | | | |
Collapse
|
145
|
Koós M, Steiner B, Micová J, Langer V, Durík M, Gyepesová D. Synthesis and structure determination of some sugar amino acids related to alanine and 6-deoxymannojirimycin. Carbohydr Res 2001; 332:351-61. [PMID: 11438092 DOI: 10.1016/s0008-6215(01)00109-4] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
(5'R)-5'-Methyl-5'-[methyl (4S)-2,3-O-isopropylidene-beta-L-erythrofuranosid-4-C-yl]-imidazolidin-2',4'-dione was synthesised starting from methyl 6-deoxy-2,3-O-isopropylidene-alpha-D-lyxo-hexofuranosid-5-ulose applying the Bucherer-Bergs reaction. Its 5'-R configuration was confirmed by X-ray crystallography. Corresponding alpha-amino acid-methyl (5R)-5-amino-5-C-carboxy-5,6-dideoxy-alpha-D-lyxo-hexofuranoside (alternative name: 2-[methyl (4S)-2,3-O-isopropylidene-beta-L-erythrofuranosid-4-C-yl]-D-alanine) was obtained from the above hydantoin by acid hydrolysis of the isopropylidene group followed by basic hydrolysis of the hydantoin ring. Total deprotection afforded 5-C-carboxy-6-deoxymannojirimycin. Analogously, methyl (5S)-5-amino-5-C-carboxy-5,6-dideoxy-alpha-L-lyxo-hexofuranoside and 5-C-carboxy-6-deoxy-L-mannojirimycin were prepared from the corresponding (5'S)-5'-methyl-5'-[methyl (4R)-2,3-O-isopropylidene-beta-D-erythrofuranosid-4-C-yl]-imidazolidin-2',4'-dione starting from methyl 6-deoxy-2,3-O-isopropylidene-alpha-L-lyxo-hexofuranosid-5-ulose.
Collapse
Affiliation(s)
- M Koós
- Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, SK-84238, Bratislava, Slovak Republic.
| | | | | | | | | | | |
Collapse
|
146
|
Hoja-Lukowicz D, Lityńska A, Wójczyk BS. Affinity chromatography of branched oligosaccharides in rat liver beta-glucuronidase. JOURNAL OF CHROMATOGRAPHY. B, BIOMEDICAL SCIENCES AND APPLICATIONS 2001; 755:173-83. [PMID: 11393703 DOI: 10.1016/s0378-4347(01)00057-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Rat liver microsomal and lysosomal beta-glucuronidase-derived glycopeptides were obtained by extensive Pronase digestion followed by N-[14C]acetylation and desialylation by neuraminidase treatment. These glycopeptides were studied by sequential chromatography on lectin-affinity columns such as concanavalin A, lentil lectin, Phaseolus vulgaris erythroagglutinin, Ricinus communis agglutinin I, Triticum vulgaris agglutinin, Glycine max agglutinin and Ulex europaeus agglutinin. Using serial lectin affinity chromatography approach combined with neuraminidase treatment allowed us to show the unexpected presence of complex tri- and/or tetraantennary type glycans (40.8 and 17.0% for microsomal and lysosomal enzyme, respectively). Moreover, the application of neuraminidase treatment revealed that complex biantennary type glycans, present on lysosomal beta-glucuronidase, are almost fully sialylated while the same type of glycans present on microsomal enzyme do not contain sialic acid. Furthermore, the results obtained confirmed that microsomal and lysosomal beta-glucuronidases possess high mannose and/or hybrid type glycans (19.6 and 36.6%, respectively), and complex biantennary type glycans (38.9 and 46.4%, respectively).
Collapse
Affiliation(s)
- D Hoja-Lukowicz
- Department of Animal Physiology, Institute of Zoology, Jagiellonian University, Kraków, Poland.
| | | | | |
Collapse
|
147
|
Bosch M, Knudsen JS, Derksen J, Mariani C. Class III pistil-specific extensin-like proteins from tobacco have characteristics of arabinogalactan proteins. PLANT PHYSIOLOGY 2001; 125:2180-8. [PMID: 11299397 PMCID: PMC88873 DOI: 10.1104/pp.125.4.2180] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2000] [Revised: 11/08/2000] [Accepted: 12/15/2000] [Indexed: 05/20/2023]
Abstract
Class III pistil-specific extensin-like proteins (PELPIII) are specifically localized in the intercellular matrix of tobacco (Nicotiana tabacum) styles. After pollination the majority of PELPIII are translocated into the callosic layer and the callose plugs of the pollen tubes, which could suggest a function of PELPIII in pollen tube growth. PELPIII may represent one of the chemical and/or physical factors from the female sporophytic tissue that contributes to the difference between in vivo and in vitro pollen tube growth. PELPIII glycoproteins were purified and biochemically characterized. Because of their high proline (Pro) and hydroxy-Pro (Hyp) content, PELPIII proteins belong to the class of Pro/Hyp-rich glycoproteins. The carbohydrate moiety of PELPIII is attached through O-glycosidic linkages and comprises more than one-half the total glycoprotein. Deglycosylation of PELPIII revealed two backbones, both reacting with PELPIII-specific antibodies. N-terminal amino acid sequencing of these backbones showed that PELPIII is encoded by the MG14 and MG15 genes. Two heterogeneous N-terminal sequences of MG14 and MG15, both starting downstream of the predicted signal peptide cleavage site, seem to be present, which indicates a novel N-terminal processing. Monosaccharide analysis showed that the carbohydrate moiety of PELPIII almost completely consists of arabinose and galactose in an equal molar ratio. Carbohydrate linkage analysis showed terminal and 2-linked arabinofuranosyl residues, as well as terminal and 6-, 3-, and 3,6-linked galactopyranosyl residues to be present, indicating the presence of both extensin-like and Type II arabinogalactan oligosaccharide units. The ability of beta-glucosyl Yariv reagent to bind with PELPIII confirmed the arabinogalactan protein-like characteristics of these proteins.
Collapse
Affiliation(s)
- M Bosch
- Graduate School of Experimental Plant Sciences, Department of Experimental Botany, University of Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.
| | | | | | | |
Collapse
|
148
|
Jedrzejas MJ. Structural and functional comparison of polysaccharide-degrading enzymes. Crit Rev Biochem Mol Biol 2001; 35:221-51. [PMID: 10907797 DOI: 10.1080/10409230091169195] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Sugar molecules as well as enzymes degrading them are ubiquitously present in physiological systems, especially for vertebrates. Polysaccharides have at least two aspects to their function, one due to their mechanical properties and the second one involves multiple regulatory processes or interactions between molecules, cells, or extracellular space. Various bacteria exert exogenous pressures on their host organism to diversity glycans and their structures in order for the host organism to evade the destructive function of such microbes. Many bacterial organism produce glycan-degrading enzymes in order to facilitate their invasion of host tissues. Such polysaccharide degrading enzymes utilize mainly two modes of polysaccharide-degradation, a hydrolysis and a beta-elimination process. The three-dimensional structures of several of these enzymes have been elucidated recently using X-ray crystallography. There are many common structural motifs among these enzymes, mainly the presence of an elongated cleft transversing these molecules which functions as a polysaccharide substrate binding site as well as the catalytic site for these enzymes. The detailed structural information obtained about these enzymes allowed formulation of proposed mechanisms of their action. The polysaccharide lyases utilize a proton acceptance and donation mechanism (PAD), whereas polysaccharide hydrolases use a direct double displacement (DD) mechanism to degrade their substrates.
Collapse
Affiliation(s)
- M J Jedrzejas
- Department of Microbiology, University of Alabama at Birmingham, 35294-2041, USA
| |
Collapse
|
149
|
Fahmi NE, Golovine S, Wang B, Hecht SM. Studies toward the site specific incorporation of sugars into proteins: synthesis of glycosylated aminoacyl-tRNAs. Carbohydr Res 2001; 330:149-64. [PMID: 11217968 DOI: 10.1016/s0008-6215(00)00289-5] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
A series of glycosylated serine derivatives was synthesized from peracetylated sugars and Fmoc-protected serine; these were chemically esterified with the tris-(tetrabutylammonium) salt of pdCpA. The fully protected and deprotected glycosylated aminoacyl pdCpAs were ligated enzymatically to an abbreviated tRNA (tRNA-C(OH)) to provide the title compounds that are key intermediates in the elaboration of glycoproteins using readthrough of a nonsense codon.
Collapse
Affiliation(s)
- N E Fahmi
- Department of Chemistry, University of Virginia, Charlottesville 22901, USA
| | | | | | | |
Collapse
|
150
|
Tauber R, Reher K, Helling K, Scherer H. Symposium on 'Morphology and Physiology of Semicircular Canal Ampulla'. Complex carbohydrates. Structure and function with respect to the glycoconjugate composition of the cupula of the semicircular canals. ACTA ACUST UNITED AC 2001. [DOI: 10.2187/bss.15.362] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|